Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-12

Clinical Trial Update: Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating the efficacy and safety of adding dexmedetomidine to a modified pectoral nerve block in female breast cancer surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: South Egypt Cancer Institute | Conditions: Breast Cancer Female | Phase 3 | Status: COMPLETED